Literature DB >> 8683440

Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states.

B S Kendrick1, A Dong, S D Allison, M C Manning, J F Carpenter.   

Abstract

Maintaining a native-like structure of protein pharmaceuticals during lyophilization is an important aspect of formulation. Infrared spectroscopy can be used to evaluate the effectiveness of formulations in protecting the secondary structural integrity of proteins in the dried solid. This necessitates making quantitative comparisons of the overall similarity of infrared spectra in the conformationally sensitive amide I region. We initially used the correlation coefficient r, as defined by Prestrelski et al. (Biophys. J. 1993, 65, 661-671), for this quantitation. Occasionally, we noticed that the r value did not agree with a visual assessment of the spectral similarity. In some cases this was due to an offset in baselines, which led artifactually to an unreasonably low r value. Conversely, if the spectra were baseline corrected and there existed a large similarity between peak positions, but differences in relative peak heights, the r value would be unreasonably high. Our approach to avoiding these problems is to use area-normalized second-derivative spectra. We have found that quantitating the area of overlap between area-normalized spectra provides a reliable, objective method to compare overall spectral similarity. In the current report, we demonstrate this method with selected protein spectra, which were taken from experiments where unfolding was induced by lyophilization or guanidine hydrochloride, and artificial data sets. With this analysis, we document how problems associated with calculation of the correlation coefficient, r, are avoided.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683440     DOI: 10.1021/js950332f

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  20 in total

1.  Stability of human serum albumin during bioprocessing: denaturation and aggregation during processing of albumin paste.

Authors:  J J Lin; J D Meyer; J F Carpenter; M C Manning
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  The use of disaccharides in inhibiting enzymatic activity loss and secondary structure changes in freeze-dried β-galactosidase during storage.

Authors:  Ville Petteri Heljo; Kirsi Jouppila; Timo Hatanpää; Anne M Juppo
Journal:  Pharm Res       Date:  2010-10-22       Impact factor: 4.200

3.  Thermal and alkaline denaturation of bovine beta-casein.

Authors:  Phoebe X Qi; Edward D Wickham; Harold M Farrell
Journal:  Protein J       Date:  2004-08       Impact factor: 2.371

4.  FTIR and nDSC as analytical tools for high-concentration protein formulations.

Authors:  Susanne Matheus; Wolfgang Friess; Hanns-Christian Mahler
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

5.  Stability improvement of a liquid enzyme product.

Authors:  Núria Jiménez; Maria Luisa Garcia; Javier Galán; Alberto Vallet; Geoffrey Owen; G Michael Wall
Journal:  AAPS PharmSciTech       Date:  2009-11-04       Impact factor: 3.246

6.  High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.

Authors:  Sébastien Dasnoy; Nancy Dezutter; Dominique Lemoine; Vivien Le Bras; Véronique Préat
Journal:  Pharm Res       Date:  2011-03-12       Impact factor: 4.200

7.  Elucidation of degradants in acidic peak of cation exchange chromatography in an IgG1 monoclonal antibody formed on long-term storage in a liquid formulation.

Authors:  Sejal Gandhi; Da Ren; Gang Xiao; Pavel Bondarenko; Christopher Sloey; Margaret Speed Ricci; Sampathkumar Krishnan
Journal:  Pharm Res       Date:  2011-08-16       Impact factor: 4.200

8.  Long-term and high-temperature storage of supercritically-processed microparticulate protein powders.

Authors:  M A Winters; P G Debenedetti; J Carey; H G Sparks; S U Sane; T M Przybycien
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

9.  Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state.

Authors:  B S Kendrick; B S Chang; T Arakawa; B Peterson; T W Randolph; M C Manning; J F Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

10.  Counteracting effects of thiocyanate and sucrose on chymotrypsinogen secondary structure and aggregation during freezing, drying, and rehydration.

Authors:  S D Allison; A Dong; J F Carpenter
Journal:  Biophys J       Date:  1996-10       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.